Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.69 |
| ▸ | CA6 | P23280 | 5/20 | 0.69 |
| ▸ | CA7 | P43166 | 5/20 | 0.69 |
| ▸ | CA9 | Q16790 | 5/20 | 0.69 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.69 |
| ▸ | CA5B | Q9Y2D0 | 5/20 | 0.69 |
| ▸ | CA2 | P00918 | 4/20 | 0.69 |
| ▸ | CA4 | P22748 | 4/20 | 0.69 |
| ▸ | CA5A | P35218 | 4/20 | 0.69 |
| ▸ | CA3 | P07451 | 3/20 | 0.69 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.69 |
| ▸ | LMNA | P02545 | 2/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.69 |
| ▸ | CA1 | P00915 | 2/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.69 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.65 |
| ▸ | MEN1 | O00255 | 3/20 | 0.62 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.62 |
| ▸ | RECQL | P46063 | 2/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL911151 | 1.00 | — | — | |
| SCHEMBL18427300 | 1.00 | CA12 (0.69) | CA12CA6CA7CA9CA14 | |
| SCHEMBL1247701 | 1.00 | CA12 (0.69) | CA12CA6CA7CA9CA14 | |
| SCHEMBL10081836 | 1.00 | CA12 (0.69) | CA12CA6CA7CA9CA14 | |
| Ammonia Solution, Strong SCHEMBL3076469 | 0.97 | CA12 (0.65) | CA12CA6CA7CA9CA14 | |
| SCHEMBL11427378 | 0.97 | CA12 (0.67) | CA12CA6CA7CA9CA14 | |
| SCHEMBL10874057 | 0.97 | CA12 (0.62) | CA12CA6CA7CA9CA14 | |
| SCHEMBL878944 | 0.94 | CYP2C19 (0.72) | CA12CA6CA7CA9CA14 | |
| SCHEMBL199119 | 0.94 | — | — | |
| SCHEMBL8624359 | 0.94 | CA12 (0.60) | CA12CA6CA7CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 190 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4211146-B1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | UNIV BAR ILAN (IL) | 2026-05-20 | — | — | EP | claimed |
| CN-122005879-A | Modified GRPR antagonist peptides for cancer imaging and treatment | 慕尼黑工业大学 | 2026-05-12 | — | — | CN | claimed |
| US-12616760-B2 | Synthetic cyclic peptide mimetics | BAR ILAN UNIVERSITY (IL) | 2026-05-05 | — | — | US | claimed |
| US-12576168-B2 | Peptide PET/SPECT probes specific to oncoproteins in tumor extracellular matrix | CASE WESTERN RESERVE UNIVERSITY (US) | 2026-03-17 | — | — | US | claimed |
| US-20250387522-A1 | PSMA TARGETED PET AND FLUORESCENCE IMAGING COMPOUNDS | UNIV CASE WESTERN RESERVE (US) | 2025-12-25 | — | — | US | claimed |
| CN-114927777-B | Ultrahigh-lithium-content material and self-supplementing lithium composite positive electrode material | 中国科学院化学研究所 | 2025-06-17 | — | — | CN | claimed |
| US-20250064995-A1 | PSMA TARGETED COMPOUNDS AND USES THEREOF | CASE WESTERN RESERVE UNIVERSITY | 2025-02-27 | — | — | US | claimed |
| US-20240374763-A1 | DIAGNOSIS AND MONITORING USING EXTRADOMAIN-B FIBRONECTIN TARGETED PROBES | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-11-14 | — | — | US | claimed |
| CN-118702638-A | 1,4,7, 10-Tetranitrogen dodecane derivative, preparation method and application thereof in synthesis of gadolinium complex | 上海凌凯科技股份有限公司 | 2024-09-27 | — | — | CN | claimed |
| US-20240316225-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | BAR ILAN UNIVERSITY (IL) | 2024-09-26 | — | — | US | claimed |
| WO-2009111273-A2 | PEPTIDE TARGETING IMAGING AGENTS AND METHODS OF USE THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-09-11 | — | — | WO | claimed |
| EP-2081979-A2 | DENDRIMERS AND METHODS OF MAKING AND USING THEREOF | University of Utah Research Foundation (US) | 2009-07-29 | — | — | EP | claimed |
| WO-2009055542-A1 | USE OF MRI CONTRAST AGENTS FOR EVALUATING THE TREATMENT OF TUMORS | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-04-30 | — | — | WO | claimed |
| WO-2008121153-A2 | DENDRIMERS AND METHODS OF MAKING AND USING THEREOF | UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2008-10-09 | — | — | WO | claimed |
| US-6509001-B1 | Peptide covalently linked to radioactive metal or iodine chelator; diagnostic and therapeutic modalities against cancer; lung and ovarian adenocarcinoma, breast cancers and lymphomas | DIATIDE, INC. | 2003-01-21 | — | — | US | claimed |
| EP-0975669-A1 | CALCITONIN RECEPTOR-BINDING PEPTIDES | Diatide, Inc. (US) | 2000-02-02 | — | — | EP | claimed |
| WO-1998049196-A1 | CALCITONIN RECEPTOR-BINDING PEPTIDES | DIATIDE, INC. (US) | 1998-11-05 | — | — | WO | claimed |
| EP-0750610-A1 | PIPERIDYL-4-SUBSTITUTED THYROSINE DERIVATIVES AS SCINTIGRAPHIC IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOSIS | Diatide, Inc. (US) | 1997-01-02 | — | — | EP | claimed |
| EP-0296522-B1 | Functionalized polyamine chelants and rhodium complexes thereof and process for their preparation | DOW CHEMICAL CO (US) | 1996-09-25 | — | — | EP | claimed |
| WO-1995025720-A1 | PIPERIDYL-4-SUBSTITUTED THYROSINE DERIVATIVES AS SCINTIGRAPHIC IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOSIS | DIATECH, INC. (US) | 1995-09-28 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12616760-B2 | Synthetic cyclic peptide mimetics | TPX2, IAPP, HAX1 | CA12 986/4885CA6 424/4885CA7 598/4885 |
| US-12576168-B2 | Peptide PET/SPECT probes specific to oncoproteins in tumor extracellular matrix | FN1, INHA, EDNRB | CA12 1211/4885CA6 2038/4885CA7 1280/4885 |
| US-20250387522-A1 | PSMA TARGETED PET AND FLUORESCENCE IMAGING COMPOUNDS | PSMA3, PSMA1, PSMA7 | CA12 47/4885CA6 31/4885CA7 19/4885 |
| US-20240316225-A1 | SYNTHETIC CYCLIC PEPTIDE MIMETICS | IAPP, QPCTL, DNPEP | CA12 495/4885CA6 1452/4885CA7 1539/4885 |
| US-20250064995-A1 | PSMA TARGETED COMPOUNDS AND USES THEREOF | FOLH1, PSMA6, PSMA2 | CA12 35/4885CA6 71/4885CA7 95/4885 |
| US-20240374763-A1 | DIAGNOSIS AND MONITORING USING EXTRADOMAIN-B FIBRONECTIN TARGETED PROBES | FN1, EDNRB, FGB | CA12 1477/4885CA6 3555/4885CA7 3011/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.